Sort   by:  
 Page size 
TranscriptomicsIdentification of a genomic signature in BRCA1-mutated triple negative breast cancer by Comparative Genomic Hybridization
Determination of recurrent chromosomal aberrations in Luninal A, Luminal B, HER2-positve, and triple negative breast cancers 131 samples, Tumour DNA vs Normal DNA
ORGANISM(S): Homo sapiens 
2015-12-10 | E-GEOD-54140 | biostudies-arrayexpress
UnknownExtended benefit from sequential administration of docetaxel after standard fluorouracil, epirubicin, and cyclophosphamide regimen for node-positive breast cancer: the 8-year follow-up results of the UNICANCER-PACS01 trial.
Not available
S-EPMC3399644 | biostudies-literature
UnknownIdentification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer.
Not available
S-EPMC4303204 | biostudies-literature
UnknownPaclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
Not available
S-EPMC10622534 | biostudies-literature
Sort   by:  
 Page size